Related Experiment Video
Updated: Jan 21, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
Anticancer Activity of Dinitrosyl Iron Complex (NO Donor) on the Multiple Myeloma Cells
N P Akentieva1,2, N A Sanina3,4, T R Prichodchenko3
1Institute of Problems of Chemical Physics, Russian Academy of Sciences, 142432, Chernogolovka, Moscow oblast, Russia. na_aken@icp.ac.ru.
Abstract:
The results of the study of the effect of a mononuclear dinitrosyl iron complex (DNIC7) with functional sulfur-containing ligands (NO donors) on the viability of multiple myeloma cells are presented. It was shown that DNIC7 decreased cell viability and inhibited the proliferation of multiple myeloma cells, i.e., exhibits cytotoxic properties. Fluorescent analysis showed that the DNIC7 compound decreases the level of intracellular glutathione and increases the level of reactive oxygen species in multiple myeloma cells. It is assumed that DNIC7 has a therapeutic potential for the treatment of cancer.
Insights
A novel dinitrosyl iron complex (DNIC7) demonstrated cytotoxic effects against multiple myeloma cells. This compound reduced cell viability and proliferation, suggesting potential as a cancer therapeutic.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Multiple myeloma is a cancer of plasma cells.
- Developing novel therapeutic agents is crucial for cancer treatment.
- Dinitrosyl iron complexes (DNICs) are being investigated for their biological activities.
Purpose of the Study:
- To investigate the effect of a mononuclear dinitrosyl iron complex (DNIC7) on multiple myeloma cells.
- To determine the cytotoxic properties and underlying mechanisms of DNIC7.
Main Methods:
- Cell viability assays were performed.
- Cell proliferation was measured.
- Fluorescent analysis was used to assess intracellular glutathione and reactive oxygen species levels.
Main Results:
- DNIC7 significantly decreased the viability of multiple myeloma cells.
- DNIC7 inhibited the proliferation of multiple myeloma cells.
- DNIC7 treatment led to decreased intracellular glutathione and increased reactive oxygen species.
Conclusions:
- DNIC7 exhibits cytotoxic properties against multiple myeloma cells.
- The mechanism involves modulation of redox balance.
- DNIC7 shows therapeutic potential for cancer treatment.
Related Concept Videos
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Multiple Allele Traits
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Multiple Regression
Farmers can use multiple regression to determine the crop yield based on more than one factor, such as water availability, fertilizer, soil properties, etc. Here, the crop yield is the response or dependent variable as it depends on the other independent variables. The analysis requires the construction of a scatter plot...
Formation of Complex Ions

